Combination of vitamin D metabolites with selective inhibitors of vitamin D metabolism

被引:0
|
作者
Schuster, I [1 ]
Egger, H [1 ]
Herzig, G [1 ]
Reddy, GS [1 ]
Vorisek, G [1 ]
机构
[1] Univ Vienna, Inst Pharmaceut Chem, A-1090 Vienna, Austria
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1alpha,25(OH)(2)D-3 exerts antiproliferative, differentiating effects on many cell types, including cancer tissues. In most of its target cells, levels of 1alpha,25(OH)(2)D-3 are regulated by local synthesis via CYP27B and metabolism via CYP24. Rapidly induced by vitamin D, CYP24 repeatedly hydroxylates the vitamin D side chain and ultimately terminates hormonal activity. Aiming at increased hormone levels, lifetime and function, numerous vitamin D analogs have been synthesized with structural modifications, which impede oxidation of the vitamin D side chain. Our group followed a different strategy, namely, blocking 1,25(OH)(2)D-3 metabolism with inhibitors of CYP24. As appropriate inhibitors, we exploited compounds termed azoles, which directly bind to the heme iron of the CYPs via an azole nitrogen and to other parts of the substrate site. We synthesized some 400 azoles and tested their potential to selectively inhibit CYP24, but not hormone synthesis by the related CYP27B. Using primary human keratinocyte cultures as the source of CYP24 and CYP27, we discovered some 50 inhibitors of CYP24 with IC50 values in the nanomole range and selectivities up to 60-fold. As the first representative of selective CYP24 inhibitors, VID400 underwent preclinical development. In human keratinocytes, VID400 stabilized levels of endogenously produced 1alpha,25(OH)(2)D-3, and thereby strongly amplified and prolonged expression of CYP24, a surrogate marker of hormonal function. In parallel, antiproliferative activity showed up at 100-fold or more lower concentrations of 1alpha,25(OH)(2)D-3. This data suggests that CYP24 inhibitors could become attractive drugs in antiproliferative therapy, used as single entities to increase or extend endogenous hormone function or in combination with low doses of potent analogs. Moreover, we used selective inhibitors as valuable tools to (a) elucidate regulatory mechanisms of vitamin D synthesis and metabolism, (b) determine intrinsic activities of the otherwise highly transient vitamin D metabolites and (c) model the active sites of CYP24 and CYP27B.(C) Springer-Verlag Berlin Heidelberg 2003.
引用
收藏
页码:169 / 188
页数:20
相关论文
共 50 条
  • [21] Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes
    Brandi, M. L.
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2010, 7 (03) : 243 - 250
  • [22] Inhibition of vitamin D hydroxylases and the role of metabolites in the vitamin D cascade
    Schuster, I
    Astecker, N
    Egger, H
    Reddy, S
    Herzig, G
    Schmid, H
    Vorisek, G
    FASEB JOURNAL, 1997, 11 (09): : A823 - A823
  • [23] VITAMIN-D - METABOLITES
    KUMAR, R
    CLINICAL CHEMISTRY, 1981, 27 (06) : 966 - 967
  • [24] REGULATION OF MATRIX VESICLE METABOLISM BY VITAMIN-D METABOLITES
    BOYAN, BD
    SCHWARTZ, Z
    SWAIN, LD
    BONEWALD, LF
    KHARE, A
    CONNECTIVE TISSUE RESEARCH, 1989, 22 (1-4) : 629 - 642
  • [25] STUDIES ON METABOLITES OF VITAMIN D
    BELL, PA
    BIBLIOTHECA NUTRITIO ET DIETA, 1969, (13) : 20 - &
  • [26] VITAMIN-D METABOLISM AND THE CLINICAL ASPECTS OF MEASURING METABOLITES
    IQBAL, SJ
    ANNALS OF CLINICAL BIOCHEMISTRY, 1994, 31 : 109 - 124
  • [27] Measurements of the Vitamin D Metabolome in the Calgary Vitamin D Study: Relationship of Vitamin D Metabolites to Bone Loss
    Burt, Lauren A.
    Kaufmann, Martin
    Rose, Marianne S.
    Jones, Glenville
    Billington, Emma O.
    Boyd, Steven K.
    Hanley, David A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 (09) : 1312 - 1321
  • [28] The measurement of vitamin D metabolites part II-the measurement of the various vitamin D metabolites
    Makris, Konstantinos
    Sempos, Christopher
    Cavalier, Etienne
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 19 (02): : 97 - 107
  • [29] SYNTHESIS OF OXA-ANALOGS OF VITAMIN-D - THE DESIGN OF POTENTIAL INHIBITORS OF VITAMIN-D METABOLISM
    BARRACK, SA
    OKAMURA, WH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1987, 194 : 13 - MEDI
  • [30] USE OF VITAMIN-D METABOLITES IN THERAPEUTICS .1. METABOLISM AND PHYSIOLOGICAL-ACTIVITY OF VITAMIN-D
    KUNTZ, D
    WILHELM, F
    REVUE DU RHUMATISME, 1987, 54 (01): : 73 - 77